Cargando…

Multiomic study of skin, peripheral blood, and serum: is serum proteome a reflection of disease process at the end-organ level in systemic sclerosis?

BACKGROUND: Serum proteins can be readily assessed during routine clinical care. However, it is unclear to what extent serum proteins reflect the molecular dysregulations of peripheral blood cells (PBCs) or affected end-organs in systemic sclerosis (SSc). We conducted a multiomic comparative analysi...

Descripción completa

Detalles Bibliográficos
Autores principales: Farutin, Victor, Kurtagic, Elma, Pradines, Joël R., Capila, Ishan, Mayes, Maureen D., Wu, Minghua, Manning, Anthony M., Assassi, Shervin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8518248/
https://www.ncbi.nlm.nih.gov/pubmed/34654463
http://dx.doi.org/10.1186/s13075-021-02633-5
_version_ 1784584182528212992
author Farutin, Victor
Kurtagic, Elma
Pradines, Joël R.
Capila, Ishan
Mayes, Maureen D.
Wu, Minghua
Manning, Anthony M.
Assassi, Shervin
author_facet Farutin, Victor
Kurtagic, Elma
Pradines, Joël R.
Capila, Ishan
Mayes, Maureen D.
Wu, Minghua
Manning, Anthony M.
Assassi, Shervin
author_sort Farutin, Victor
collection PubMed
description BACKGROUND: Serum proteins can be readily assessed during routine clinical care. However, it is unclear to what extent serum proteins reflect the molecular dysregulations of peripheral blood cells (PBCs) or affected end-organs in systemic sclerosis (SSc). We conducted a multiomic comparative analysis of SSc serum profile, PBC, and skin gene expression in concurrently collected samples. METHODS: Global gene expression profiling was carried out in skin and PBC samples obtained from 49 SSc patients enrolled in the GENISOS observational cohort and 25 unaffected controls. Levels of 911 proteins were determined by Olink Proximity Extension Assay in concurrently collected serum samples. RESULTS: Both SSc PBC and skin transcriptomes showed a prominent type I interferon signature. The examination of SSc serum profile revealed an upregulation of proteins involved in pro-fibrotic homing and extravasation, as well as extracellular matrix components/modulators. Notably, several soluble receptor proteins such as EGFR, ERBB2, ERBB3, VEGFR2, TGFBR3, and PDGF-Rα were downregulated. Thirty-nine proteins correlated with severity of SSc skin disease. The differential expression of serum protein in SSc vs. control comparison significantly correlated with the differential expression of corresponding transcripts in skin but not in PBCs. Moreover, the differentially expressed serum proteins were significantly more connected to the Well-Associated-Proteins in the skin than PBC gene expression dataset. The assessment of the concordance of between-sample similarities revealed that the molecular profile of serum proteins and skin gene expression data were significantly concordant in patients with SSc but not in healthy controls. CONCLUSIONS: SSc serum protein profile shows an upregulation of profibrotic cytokines and a downregulation of soluble EGF and other key receptors. Our multilevel comparative analysis indicates that the serum protein profile in SSc correlates more closely with molecular dysregulations of skin than PBCs and might serve as a reflection of disease severity at the end-organ level. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13075-021-02633-5.
format Online
Article
Text
id pubmed-8518248
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-85182482021-10-20 Multiomic study of skin, peripheral blood, and serum: is serum proteome a reflection of disease process at the end-organ level in systemic sclerosis? Farutin, Victor Kurtagic, Elma Pradines, Joël R. Capila, Ishan Mayes, Maureen D. Wu, Minghua Manning, Anthony M. Assassi, Shervin Arthritis Res Ther Research Article BACKGROUND: Serum proteins can be readily assessed during routine clinical care. However, it is unclear to what extent serum proteins reflect the molecular dysregulations of peripheral blood cells (PBCs) or affected end-organs in systemic sclerosis (SSc). We conducted a multiomic comparative analysis of SSc serum profile, PBC, and skin gene expression in concurrently collected samples. METHODS: Global gene expression profiling was carried out in skin and PBC samples obtained from 49 SSc patients enrolled in the GENISOS observational cohort and 25 unaffected controls. Levels of 911 proteins were determined by Olink Proximity Extension Assay in concurrently collected serum samples. RESULTS: Both SSc PBC and skin transcriptomes showed a prominent type I interferon signature. The examination of SSc serum profile revealed an upregulation of proteins involved in pro-fibrotic homing and extravasation, as well as extracellular matrix components/modulators. Notably, several soluble receptor proteins such as EGFR, ERBB2, ERBB3, VEGFR2, TGFBR3, and PDGF-Rα were downregulated. Thirty-nine proteins correlated with severity of SSc skin disease. The differential expression of serum protein in SSc vs. control comparison significantly correlated with the differential expression of corresponding transcripts in skin but not in PBCs. Moreover, the differentially expressed serum proteins were significantly more connected to the Well-Associated-Proteins in the skin than PBC gene expression dataset. The assessment of the concordance of between-sample similarities revealed that the molecular profile of serum proteins and skin gene expression data were significantly concordant in patients with SSc but not in healthy controls. CONCLUSIONS: SSc serum protein profile shows an upregulation of profibrotic cytokines and a downregulation of soluble EGF and other key receptors. Our multilevel comparative analysis indicates that the serum protein profile in SSc correlates more closely with molecular dysregulations of skin than PBCs and might serve as a reflection of disease severity at the end-organ level. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13075-021-02633-5. BioMed Central 2021-10-15 2021 /pmc/articles/PMC8518248/ /pubmed/34654463 http://dx.doi.org/10.1186/s13075-021-02633-5 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Farutin, Victor
Kurtagic, Elma
Pradines, Joël R.
Capila, Ishan
Mayes, Maureen D.
Wu, Minghua
Manning, Anthony M.
Assassi, Shervin
Multiomic study of skin, peripheral blood, and serum: is serum proteome a reflection of disease process at the end-organ level in systemic sclerosis?
title Multiomic study of skin, peripheral blood, and serum: is serum proteome a reflection of disease process at the end-organ level in systemic sclerosis?
title_full Multiomic study of skin, peripheral blood, and serum: is serum proteome a reflection of disease process at the end-organ level in systemic sclerosis?
title_fullStr Multiomic study of skin, peripheral blood, and serum: is serum proteome a reflection of disease process at the end-organ level in systemic sclerosis?
title_full_unstemmed Multiomic study of skin, peripheral blood, and serum: is serum proteome a reflection of disease process at the end-organ level in systemic sclerosis?
title_short Multiomic study of skin, peripheral blood, and serum: is serum proteome a reflection of disease process at the end-organ level in systemic sclerosis?
title_sort multiomic study of skin, peripheral blood, and serum: is serum proteome a reflection of disease process at the end-organ level in systemic sclerosis?
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8518248/
https://www.ncbi.nlm.nih.gov/pubmed/34654463
http://dx.doi.org/10.1186/s13075-021-02633-5
work_keys_str_mv AT farutinvictor multiomicstudyofskinperipheralbloodandserumisserumproteomeareflectionofdiseaseprocessattheendorganlevelinsystemicsclerosis
AT kurtagicelma multiomicstudyofskinperipheralbloodandserumisserumproteomeareflectionofdiseaseprocessattheendorganlevelinsystemicsclerosis
AT pradinesjoelr multiomicstudyofskinperipheralbloodandserumisserumproteomeareflectionofdiseaseprocessattheendorganlevelinsystemicsclerosis
AT capilaishan multiomicstudyofskinperipheralbloodandserumisserumproteomeareflectionofdiseaseprocessattheendorganlevelinsystemicsclerosis
AT mayesmaureend multiomicstudyofskinperipheralbloodandserumisserumproteomeareflectionofdiseaseprocessattheendorganlevelinsystemicsclerosis
AT wuminghua multiomicstudyofskinperipheralbloodandserumisserumproteomeareflectionofdiseaseprocessattheendorganlevelinsystemicsclerosis
AT manninganthonym multiomicstudyofskinperipheralbloodandserumisserumproteomeareflectionofdiseaseprocessattheendorganlevelinsystemicsclerosis
AT assassishervin multiomicstudyofskinperipheralbloodandserumisserumproteomeareflectionofdiseaseprocessattheendorganlevelinsystemicsclerosis